NYSE:GME - Post Discussion
GameStop Corp
> Assess the company's main drug compound in a broader context
Post by
SophiaBrown on Aug 17, 2021 3:29am
Assess the company's main drug compound in a broader context
FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) To Evaluate Ultramicronized Palmitoylethanolamide (PEA), or FSD201, in a Broader Sense recruited an outside adviser to review its key medicinal molecule, ultramicronized palmitoylethanolamide (PEA), or FSD201, in a broader sense.
Be the first to comment on this post